Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tacrolimus Versus Cyclophosphamide as Treatment for Diffuse Proliferative or Membranous Lupus Nephritis: Prospective Cohort Study

NCT01207297 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT01207297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01207297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tacrolimus Versus Cyclophosphamide as Treatment for Diffuse Proliferative or Membranous Lupus Nephritis: Prospective Cohort Study
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2003
Completion date
June 30, 2010
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, lupus nephritis, renal insufficiency, sle